One Audit, Five Markets: Navigating the Medical Device Single Audit Program

This episode demystifies the Medical Device Single Audit Program (MDSAP), a unified approach that allows MedTech manufacturers to satisfy the quality management system requirements of five major markets—Australia, Brazil, Canada, Japan, and the U.S.—through a single audit. Learn about its history, the audit cycle, and the specific benefits for accessing each market, including its mandatory status in Canada. • What exactly is the Medical Device Single Audit Program (MDSAP)? • Which five major global markets can be accessed through one audit? • How does MDSAP reduce audit fatigue and save resources for manufacturers? • In which country is MDSAP participation mandatory for medical device licensing? • What does the three-year MDSAP audit cycle involve for a device maker? • How do regulatory bodies like the U.S. FDA and Health Canada utilize MDSAP reports? • What are the tangible benefits of adopting MDSAP for your company? • Could MDSAP streamline your path to ISO 13485 certification and beyond? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.